StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

Artelo Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $3.82M, down 37.0% year over year. For fiscal 2025 it was $5.42M, down 9.5% from the year before. The highest annual figure on record is $5.99M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.42M-9.5%
FY2024Dec 31, 2024$5.99M+5.2%
FY2023Dec 31, 2023$5.70M+100.6%
FY2021Aug 31, 2021$2.84M+47.9%
FY2020Aug 31, 2020$1.92M+75.7%
FY2019Aug 31, 2019$1.09M-12.6%
FY2018Aug 31, 2018$1.25M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$876.00K-53.2%
Q1 FY2026CQ1 2026Mar 31, 2026$773.00K-44.1%
Q4 FY2025CQ4 2025Dec 31, 2025$893.00K-63.9%
Q3 FY2025CQ3 2025Sep 30, 2025$1.28M+292.3%
Q2 FY2025CQ2 2025Jun 30, 2025$1.87M+11.0%
Q1 FY2025CQ1 2025Mar 31, 2025$1.38M-8.2%
Q4 FY2024CQ4 2024Dec 31, 2024$2.48M+16.6%
Q3 FY2024CQ3 2024Sep 30, 2024$325.00K-79.5%
Q2 FY2024CQ2 2024Jun 30, 2024$1.69M+124.1%
Q1 FY2024CQ1 2024Mar 31, 2024$1.51M+22.0%
Q4 FY2023CQ4 2023Dec 31, 2023$2.12M+245.1%
Q3 FY2023CQ3 2023Sep 30, 2023$1.59M+66.6%
Q2 FY2023CQ2 2023Jun 30, 2023$752.00K+13.4%
Q1 FY2023CQ1 2023Mar 31, 2023$1.24M+107.6%
Q4 FY2021CQ3 2021Aug 31, 2021$615.46K+126.2%
Q3 FY2021CQ2 2021May 31, 2021$951.20K+267.7%
Q2 FY2021CQ1 2021Feb 28, 2021$663.36K-8.0%
Q1 FY2021CQ4 2020Nov 30, 2020$595.00K-10.8%
Q4 FY2020CQ3 2020Aug 31, 2020$272.08K+16.4%
Q3 FY2020CQ2 2020May 31, 2020$258.68K+40.4%
Q2 FY2020CQ1 2020Feb 29, 2020$721.31K+47.2%
Q1 FY2020CQ4 2019Nov 30, 2019$666.94K+262.4%
Q4 FY2019CQ3 2019Aug 31, 2019$233.77K-29.7%
Q3 FY2019CQ2 2019May 31, 2019$184.20K-22.2%
Q2 FY2019CQ1 2019Feb 28, 2019$489.98K-24.3%
Q1 FY2019CQ4 2018Nov 30, 2018$184.04K+456.4%
Q4 FY2018CQ3 2018Aug 31, 2018$332.47K–
Q3 FY2018CQ2 2018May 31, 2018$236.85K–
Q2 FY2018CQ1 2018Feb 28, 2018$647.47K–
Q1 FY2018CQ4 2017Nov 30, 2017$33.08K–

More Artelo Biosciences figures

See a number that looks wrong?